Studies of insulin resistance in congenital generalized lipodystrophy

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 85, Issue 413, 1996, Pages 29-38

  Sovik O ^a   Vestergaard, H ^b   Trygstad, O ^c   Pedersen, O ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b STENO DIABETES CENTER   (Denmark)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Congenital generalized lipodystrophy; hepatic glucose release; insulin resistance; lipid oxidation; non oxidative glucose metabolism

Indexed keywords

GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; HORMONE RECEPTOR INTERACTION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPODYSTROPHY; MALE; PRIORITY JOURNAL;

EID: 0029894986     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Seip M. Generalized lipodystrophy. Ergeb Inn Med Kinderheilkd 1971;31:59-95
2. Oseid S. Studies in congenital generalized lipodystrophy (Seip-Berardinelli syndrome) I. Development of diabetes. Acta Endocrinol (Copenh) 1973;72:475-94
3. Søvik O, Oseid S. Studies in congenital generalized lipodystrophy. II. The effect of patients' plasma on glycogen synthesis in rat diaphragm and adipose tissue in vivo. Acta Endocrinol (Copenh) 1973;72:495-505
4. Søvik O, Oseid S, Øyasæter S. Studies in congenital generalized lipodystrophy. V. Circulating insulin and pro-insulin. Acta Endocrinol (Copenh) 1973;73:731-9
5. Søvik O, Oseid S. Studies in congenital generalized lipodystrophy VI. Suppressible and non-suppressible insulin-like activities of plasma. Acta Endocrinol (Copenh) 1975;79:720-8
6. Oseid S, Beck-Nielsen H, Pederscn O, Søvik O. Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med 1977;296:245-8
7. Rosenbloom AL, Goldstein S, Yip CC. Normal insulin binding to cultured fibroblasts from patients with lipoatrophic diabetes. J Clin Endocrinol Metab 1977;44:803-6
8. Dörfler H, Wieczorek A, Wolfram G, Zöllner N. Binding of insulin to fibroblasts in lipoatrophic diabetes. Res Exp Med 1977;170:161-8
9. Howard BV, Mott DM, Hidaka H, Fields RM, Katzeff H, Howard WJ, et al. Cell culture studies of a patient with congenital lipoatrophic diabetes - normal insulin binding with alterations in intracellular glucose metabolism and insulin action. Metabolism 1981;30:845-52
10. Kodama S, Kasuga M, Seki A, Ninomiya M, Sakurai T, Morishita Y, et al. Congenital generalized lipodystrophy with insulin-resistant diabetes. Eur J Pediatr 1978;127:111-9
11. Wachslicht-Rodbard H, Muggeo M, Kahn CR, Saviolakis GA, Harrison LC, Flier JS. Heterogeneity of the insulin-receptor interaction in lipoatrophic diabetes. J Clin Endocrinol Metab 1981;52:416-25
12. Golden MP, Charles MA, Arquilla ER, Myers GL, Lippe BM, Duckworth WC et al. Insulin resistance in total lipodystrophy: evidence for a pre-receptor defect in insulin action. Metabolism 1985;34:330-5
13. Aricò M, Ricordi A, Caselli D, Aschei M, Colombo A, Fratino P. Insulin receptor evaluation in congenital generalized lipodystrophy. Helv Paediatr Acta 1987;42:167-71
14. Tsukahara H, Kikuchi K, Kuzuya H, Ito E, Oda Y, Kosaki A, et al. Insulin resistance in a boy with congenital generalized lipodystrophy. Pediatr Res 1988;24:668-72
15. Kriauciunas KM, Kahn CR, Muller-Wieland D, Reddy SSK, Taub R. Altered expression and function of the insulin receptor in a family with lipoatrophic diabetes. J Clin Endocrinol Metab 1988;67:1284-93
16. Magrè J, Reynet C, Capeau J, Blivet MJ, Picard J. In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Diabetes 1988;37:421-8
17. Robert JJ, Magré J, Reynet C, Darmaun D, Picard J, Capeau J. In vivo and in vitro characterization of insulin resistance in three cases of lipoatrophic diabetes. Diabete Metab 1990;16:240-7
18. van der Vorm ER, Kiupers A, Bonenkamp JW, Kleijer WJ, Van Maldergem L, Herwig J, et al. Patients with lipodystrophic diabetes mellitus of the Seip-Berardinelli type, express normal insulin receptors. Diabetologia 1993;36:172-4
19. Magré J, Grigorescu F, Reynet C, Caron M, Capony JP, White MF, et al. Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatrophic diabetes. J Clin Endocrinol Metab 1989;69:142-50
20. Vestergaard H, Lund S, Larsen FS, Bjerrum OJ, Pedersen O. Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin resistant patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1993;91:2342-50
21. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol (Endocrinol Metab) 1979;6(3):E214-23
22. Steele R. Influence of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959;82:420-30
23. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-34
24. Bak JF, Pedersen O. Exercise-enhanced activation of glycogen synthase in human skeletal muscle. Am J Physiol (Endocrinol Metab) 1990;258:E957-63
25. Lanng S, Thorsteinsson B, Roder ME, Ørskov C, Holst JJ, Nerup J, et al. Pancreas and gut hormone responses to oral glucose and intraveneous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance. Acta Endocrinol (Copenh) 1993;128:207-14
26. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993;39:578-82
27. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975;11:541-8
28. Faber O, Binder C, Markussen J, Heding LG, Naithani VK, Kuzuya H, et al. Characterization of seven C-peptide antisera. Diabetes 1978;27:170-7
29. Kjems LL, Røder ME, Dinesen B, Hartling SG, Jørgensen PN, Binder C. Highly sensitive enzyme immunoassay of proninsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993;39:2146-50
30. Hother-Nielsen O, Schmitz O, Bak JF, Beck-Nielsen H. Enhanced hepatic insulin sensitivity, but peripheral insulin resistance in patients with type I (insulin-dependent) diabetes. Diabetologia 1987;30:834-40
31. Gray DS, Bray GA, Gemayel N, Kaplan K. Effect of obesity on bioelectrical impedance. Am J Clin Nutr 1989;50:255-60
32. De Fronzo RA. Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94
33. 13C nuclear magnetic resonance spectroscopy. N End J Med 1990;322:223-8
34. Stalmans W, Bollen M, Mvumbi L. Control of glycogen synthesis in health and disease. Diabetes/Metab Rev 1987;3:127-61
35. Klein S, Jahoor F, Wolfe RR, Stuart CA. Generalized Hpodystrophy: in vivo evidence for hypermetabolism and insulin-resistant lipid, glucose and amino acid kinetics. Metabolism 1992;41:893-6
36. Keenan BS, Kirkland RT, Garber AJ, Rubenstein AH, Holcombe JH, Potts VE, et al. The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetes. Metabolism 1980;29:1214-24
37. Beylot M, Sautot G, Laville M, Cohen R. Metabolic studies in lipoatrophic diabetes: Mechanism of hyperglycemia and evidence of resistance to insulin of lipid metabolism. Diabète Metab 1988;14:20-4
38. Robert JJ, Rakotoambinina B, Cochet I, Poussier V, Magré J, Darmaun D, et al. The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes. Diabetologia 1993;36:1288-92
39. Kahn CR. Causes of insulin resistance. Nature 1995;373:384-5
40. Kahn CR, White MF. The insulin receptor and the molecular mechanism of insulin action. J Clin Invest 1988;82:1151-56
41. Myers MG, White MF. The new elements of insulin signaling: insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 1993;42:643-50
42. Myers MG, White MF. New frontiers in insulin receptor substrate signaling. Trends Endocrinol Metab 1995;6:209-15
43. Quon MJ, Butte AJ, Taylor SI. Insulin signal transduction pathways. Trends Endocrinol Metab 1994;5:369-76
44. Walaas O, Walaas I. Second messengers identified for insulin? Trends Pharmacol Sci 1988;91:151 -2
45. Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, DaLaLuz-Sierra M, et al. Mutations in the insulin receptor gene. Endocr Rev 1992;13:566-95
46. Kadowaki T, Devins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, et al. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 1988;240:787-90
47. Yoshimasa Y, Seino S, Whittaker J, Kakehi T, Kosaki A, Kuzuya H, et al. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 1988;240:784-7
48. Schilling EE, Rechler MM, Grunfeld C, Rosenberg AM. Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance. Proc Natl Acad Sci USA 1979;76:5877-81
49. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 1976;294:739-45
50. Vestergaard H, Klein HH, Hansen T, Müller J, Skovby F, Bjørbæk C, et al. Severe insulin-resistant diabetes mellitus in patients with congenital muscle fiber type disproportion myopathy. J Clin Invest 1995;95:1925-32
51. Livingston JN, Moxley RT. Myotonic dystrophy. Phenotype-genotype and insulin resistance. Diabetes Rev 1994;2:29-42